ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: However, in the studies that did not specify NAFLD severity, significantly higher circulating ANGPTL8 levels were observed in the patients with NAFLD compared to controls (SMD: 0.48, 95% CI: 0.02, 0.93.